Education
About Us
Working with TipRanks
Follow Us
ImmunoPrecise Antibodies (IPA)
NASDAQ:IPA
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | C$ 24.52M | C$ 24.52M | C$ 20.66M | C$ 19.36M | C$ 17.91M |
| Gross Profit | C$ 13.55M | C$ 12.05M | C$ 11.56M | C$ 10.98M | C$ 11.54M |
| Operating Income | C$ -12.20M | C$ -13.76M | C$ -25.61M | C$ -15.78M | C$ -4.18M |
| EBITDA | C$ -28.86M | C$ -22.95M | C$ -21.04M | C$ -11.99M | C$ -1.42M |
| Net Income | C$ -30.23M | C$ -27.18M | C$ -26.56M | C$ -16.71M | C$ -7.34M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | C$ 10.66M | C$ 3.46M | C$ 8.28M | C$ 29.96M | C$ 41.76M |
| Total Assets | C$ 44.44M | C$ 59.99M | C$ 77.81M | C$ 93.49M | C$ 66.96M |
| Total Debt | C$ 13.40M | C$ 13.68M | C$ 7.27M | C$ 2.55M | C$ 3.46M |
| Net Debt | C$ 2.74M | C$ 10.22M | C$ -1.01M | C$ -27.42M | C$ -38.30M |
| Total Liabilities | C$ 20.82M | C$ 26.07M | C$ 20.01M | C$ 18.21M | C$ 10.04M |
| Stockholders' Equity | C$ 23.63M | C$ 33.92M | C$ 57.80M | C$ 75.28M | C$ 56.92M |
| Cash Flow | |||||
| Free Cash Flow | C$ -7.21M | C$ -5.64M | C$ -21.33M | C$ -11.18M | C$ -2.03M |
| Operating Cash Flow | C$ -6.41M | C$ -4.25M | C$ -19.83M | C$ -9.92M | C$ -600.00K |
| Investing Cash Flow | C$ -799.00K | C$ -1.56M | C$ -1.97M | C$ -5.21M | C$ -2.46M |
| Financing Cash Flow | C$ 14.89M | C$ 1.02M | C$ -621.00K | C$ 2.88M | C$ 43.38M |